Nuclear Speckle Rejuvenation Could Be the Next Frontier for Treating Neurodegeneration

Nuclear speckle rejuvenation could be the next frontier for treating neurodegeneration

Targeting cellular structures called nuclear speckles could be a completely new approach for treating proteinopathies—diseases driven by abnormal accumulation of misfolded proteins—such as Alzheimer's, Parkinson's and prion diseases, according to new research published in Nature Communications and led by the University of Pittsburgh.

Reshaping Nuclear Speckles Could Halt Alzheimer’s

A groundbreaking study reveals that reshaping nuclear speckles — tiny structures inside cell nuclei that regulate protein maintenance — could be a novel way to treat proteinopathies like Alzheimer’s, Parkinson’s, and prion diseases. Researchers found that pyrvinium pamoate, an existing FDA-approved drug, alters the surface tension of nuclear speckles, making them less round and more effective at supporting proteostasis.